CliniSys announced that Mark Spencer has joined the company as Senior Vice President of Global Strategy. A 25-year veteran in the life sciences and healthcare IT industry, Mark will be charged with driving growth globally.

As the world looks to improve public health now and after the pandemic, Mark will work closely with the senior leadership team to

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the University Hospital Brandenburg an der Havel (Brandenburg, Germany) have signed a 10-year strategic partnership to renew and expand the hospital's diagnostic and therapy options through the delivery of advanced technology solutions.

System C is close to completion on its £200m five-year investment programme in the Medway EPR, a patient management and electronic patient record system designed and built specifically for the NHS. The company is preparing for the nationwide launch of CareFlow EPR at three virtual events in February, March, and April 2022, with live demonstrations and learnings from those pioneering the use of the new system.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the introduction of the industry's first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials. The clinical-grade solution is the most advanced patient-centric ECG offering within the company's cardiac monitoring portfolio, pairing data readings comparable to clinical, site-based ECGs with Philips leading cloud-based data collection and analysis services.

One year after implementing TeleTracking's patient flow platform, Maidstone and Tunbridge Wells NHS Trust (MTW) has significantly improved capacity management and operational efficiencies across the 512-bed organisation. As part of the Trust's digital strategy, TeleTracking's software centralises capacity management and creates shared visibility and automation around staff workflows. Now a year into their digital journey,

R2G launches a new Global Annual Digital Health Business Survey - 2022 to assess the digital health industry outlook in 2022. The survey is conducted by R2G on an on-going basis annually which focuses on gathering opinions from digital health decision makers on how the digital health industry will evolve in the coming year.

Huma has bought iPLATO Healthcare, whose patient engagement software covers a network of 26.6m patients across nearly 3,000 NHS primary care organisations and whose myGP app is one of the most downloaded medical apps in the UK. The two companies will continue to operate independently but will combine their expertise to enable more proactive, predictive and personalised care for patients in a joined-up service across primary and secondary care.‏ ‏